M OST of the clinical investigation concerning nitroglycerin (glyceryl trinitrate) in recent years has centered about its influences on the coronary circulation and myocardial perfusion, and its cardiac effectiveness has recently been ascribed to a reduction in ventricular work.'-10 Widespread vasodilatation,l arterial, capillary, and venular, has been long recognized as one of the results of the drug and, more recently, a decrease in cardiac output has been noted and ascribed to reduction in venous return. The latter was assumed to result from peripheral venous pooling. It has been postulated that the sites of such pooling include the splanchnic and possibly the pulmonary beds. Since these two beds normally hold one third of the total circulating blood volume, it is of interest to investigate the extent to which they may be involved in circulatory readjustments to nitroglycerin.
Thus this study was undertaken to investigate the effects of nitroglycerin on the Work performed while Dr. Brickner was a fellow of the New York Heart Association.
Circulation, Volume XXXIII, March 1966 splanchnic, pulmonary, and systemic circulations. Method
Eighteen patients, 17 with heart disease, were studied. Details of diagnosis are given in table 1. The first 10 subjects in table 1 appear also in table 2 which presents data on systemic, pulmonary, and splanchnic effects of nitroglycerin given sublingually. The remaining eight subjects in table 1 appear also in table 3 which contains data on the circulatory effects of the drug in the systemic and pulmonary beds only.
One patient (no. 1246) had no heart disease, seven (nos. 1178, 1431, 1196, 877, 916, 855, 853) either had never been in congestive heart failure or had recovered from it, and the remaining 10 had left ventricular failure at the time of study. Hepatic function appeared to be normal as evidenced by absence of jaundice or chemical abnormalities other than slight sulfobromophthalein (BSP) retention.
All patients were studied in the postabsorptive, basal state and were without medication for at least 12 hours. Right heart catheterization was done via the left larm vein and hepatic venous catheter placement via the right arm vein. A Cournand needle was used to cannulate the peripheral artery. Cardiac output (CO) (by the Fick principle), blood pressures, splanchnic blood flow (ESBF) estimated by the BSP method, and circulating total (TBV) and splanchnic blood volumes (SBV) (by the RISA method) were measured, and systemic and splanchnic resistances were calculated according to the several methods given in more detail in a previous report.'2 All these hemodynamic measurements were made before the drug was administered. As soon as the drug dissolved, brachial and pulmonary artery blood pressures were recorded. The earliest were obtained at 15 seconds. Observations were continued, in some cases for as long as 40 or 50 minutes. As soon as the contour of the brachial artery pressure curve began to show the effects 3 ) was studied at rest, during supine leg exercise, and then during exercise with nitroglycerin. The method and evaluation of the exercise study have been presented previously.'3 One separate preliminary study of the influence of nitroglycerin on pulmonary blood volume is included. The method used has been reported earlier. 14 An adjunct study in a separate group of eight subjects who were free of cardiovascular disease was undertaken to follow contour changes in simultaneously recorded brachial and femoral arterial curves. No other parameters were followed in this group.
The dosage of sublingual nitroglycerin varied between 0.3 and 0.6 mg as indicated in tables 2 and 3. On the day before the study each subject was tested in the supine position in order to select a dose sufficient to affect the systemic blood pressure without producing any of the uncomfortable side effects, that is, headache or throbbing. Body size alone was not a reliable index of such dosage. Great care was taken to use only fresh tablets of nitroglycerin. These were specially procured and were not taken from the supply in the hospital pharmacy as the drug from the latter source was unreliable as to strength. The patient reported the moment at which the tablet had dissolved as well as any symptoms following its use. None of the patients was having anginal pain while being studied.
Results
Of the 17 in whom cardiac output was measured after nitroglycerin (tables 2 and 3), 12 (70%) had a fall, with an average Circulation, Volume XXXIII, March 1966 change of -20% and a range of -12 to -34%. This included the subject who received the drug during exercise. This occurred without relation to the level of output before administration of drug. One patient (no. 835, table 3) had a 12 to 14% rise and the remaining four individuals had no significant change in blood flow (less than 10%). Since, with the exception of the exercise study, there was no significant change in heart rate, the stroke volume fell whenever nitroglycerin elicited a fall in systemic blood flow. The time of the initial measurement of cardiac output after drug administration varied considerably from one patient to another. The earliest determination was made at 5 minutes after the drug was given and showed a fall of 20%. In the 12 subjects with a fall in cardiac output, most of the values were taken within the first half hour, and the latest measurements were secured at 42 minutes. Thus, the decrease in blood flow was not transient. In most patients the fall in output persisted at about the same level during this time as determined by the two determinations of cardiac output made after drug administration. In three, however (no. 1397 24 .8%, a normal figure, but the range was wide, 17 to 38%. This ratio tended to be lower in the last six patients in table 2 (an average of 22% as compared to 30% in the first four), all of whom were in left ventricular failure at the time of study and three of whom had had both right and left or combined ventricular failure recently. This suggests some splanchnic vasoconstriction in these six patients, a state often associated with cardiac failure,12 but this state did not appear basically to influence the reaction to the drug since two of the six had a fall in splanchnic flow and four did not.
Changes in systemic and splanchnic resistances were variable after the drug (tables 2 and 3), with modest rises and falls even in those subjects who had decreases in both systemic and splanchnic flows.
In the eight persons (nos. 1246, 1178, 1225, 1297, 1391, 1397, 1409, 1251) in whom splanchnic blood volume could be followed serially, one half had an average decrease of -42% and a range of -27 to -50, and the other half did not have any significant variation from the control value (table 2) . Four had high and four low values to begin with, using 900 to 1200 ml as a normal range with a SBV/TBV ratio of 20%. All four with a fall in this volume (nos. 1246, 1178, 1391, 1251) also had a fall in cardiac output. Three of the four without change in splanchnic blood volume also had no change in output while one (no. 1397) did have a fall in the latter. Three of the four subjects with falls in SBV (1178, 1391, 1251) also had decreases in splanchnic blood flow and the four with no change in this volume had no alterations in splanchnic flow. T'he total circulating blood volume remained unchanged after nitroglycerin in 10 subjects. Thus it would appear that when the drug does affect the splanchnic circulation ( fig. 2) , both flow and volume in this In all 18 subjects (tables 2 and 3) the responses in systemic and pulmonary arterial pressures were uniform regardless of the level of such pressures. In every patient there was a fall in brachial artery systolic pressure ranging between 12 and 30 mm Hg and in one instance reaching 50 mm Hg. T*is was accompanied by either no change or only a small fall in diastolic and mean pressure values (range, 5 to 7 and 5 to 12 mpm Hg, respectively). The pulmonary arterial systolic, diastolic, and mean all fell with the drug, l)ut the fall was greater in the systolic (6 to 18 mm Hg) than in the other two values (about 5 to 7 mm). Even when systemic arterial pressures had resumed pre-drug values late in the post-drug period, pultnonary Circulalion, Volumne XXXII, AUyrah 1966 artery pressures tended to remain below control levels. The right atrial mean or right ventricular end diastolic and hepatic vein mean pressures, which were all normal, did not change significantly. No measurements were made of peripheral venous pressure.
Accompanying this consistent response in systemic and pulmonary arterial pressures, there was always a distinctive change in the contour of brachial artery pressure pulse ( fig.  1 ). This contour change preceded any obvious pressure fall in four subjects (nos. 916, 855, 853, 835, table 3). It was characterized by a narrowing of the systolic peak (ejection phase) of the pressure curve and by a movement downward on the curve of the dicrotic notch and in some cases by its eventual obliteration. It most closely resembled the curve seen in aortic insufficiency or any peripheral vasodilatation with a rapid runoff. This contour effect was maximal early in the post-drug period, never appearing before 2 minutes and usually present by 2 to 4 minutes ( fig. 1 ), and maximal between 5 and 15 minutes. It may diminish at about 18 to 20 minutes ( fig. 1 ) as the systemic pressure may fall; both have usually subsided by 30 to 35 minutes. One subject whose arterial contour returned to normal by 18 minutes showed a reappearance of the typical alteration after a coughing spell at 45 minutes after drug. The pulmonary artery curves showed a similar change when curves were of good quality. When both brachial and femoral arterial effects were monitored simultaneously, as in the adjunct study, the contour change and pressure drop were less marked in the femoral artery and appeared later, but the position of the dicrotic notch on the femoral curve was affected also. If a systolic gradient was present between these two arteries-and it was not always so, as brachial systolic pressure exceeded femoral in some, femoral was higher than the brachial in others and in some they were equal-it disappeared after the drug was taken.
One of the most interesting results of this study was the production of pulsus alternans by nitroglycerin in eight of the 18 subjects. Five of these (nos. 1431, 1397, 1409, 1137, 1132) had no alternation before drug but definite alternans in the brachial artery after it. Alternans was noted also in the pulmonary artery in one (no. 1397). The last three of these five developed pulsus alternans in an intermittent fashion after taking the drug, but it was constant in the first two ( fig. 3 ). Alternation appeared early, by the first 2 to 4 minutes, but its arrival was not always simultaneous with either the change in the brachial arterial contour or the fall in systemic arterial pressure, both of which could precede it by 2 to 3 minutes (nos. 1397, 1137). In three patients who already had pul- Figure 3 The production of pulsus alternans in the brachial artery (BA) by nitroglycerin in a patient (no. 1397) in left ventricular failure. The calibration remains unchanged throughout the stuidy. Note the contour change at 2 minutes and 45 seconds after administration of the drug with narrowing of the systolic peak, the downward movement, and the flattening of the dicrotic notch. At 4 minutes and 30 seconds, pulsus alternans, with a systolic pressure difference of 9 mm Hg is present (no electrical alternans), and the notch is almost lost. In the final panel alternans has ceased, the pressures are almost at control values, but the contour change persists.
Circulation, Volumne XXXIII, March 1966 sus alternans before nitroglycerin-only occasionally in one case (no. 1225) and constantly in the other two (nos. 1391, 1251)the alternation became constant in the first and much more marked in the latter pair.
Pulsus alternans in the pulmonary artery, which was absent in the control period of all three of these, appeared after nitroglycerin in only one man (no. 1225). All but one (no. 1431) of the patients who developed or had an increase in pulsus alternans after the drug were in left ventricular failure. In one subject (no. 1409) who developed pulsus alternans, there was no fall in cardiac output or stroke volume. None of those with alternans had any evidence of change in the electrocardiogram.
Three of the 18 subjects in this study (nos. 1196, 1225, in 3) developed nitrite collapse between 9 and 19 minutes after administration of the drug with pallor, weakness, and dizziness accompanied by a marked arterial hypotension. In one (no. 853, table 3) it was possible to measure cardiac output before treating the collapse, and it had fallen 34%, the largest decline in output in this study, and the stroke volume was lowered 31%. Systemic peripheral resistance was unchanged. Along with the fall in brachial artery pressures those in the pulmonary artery also fell (nos. 1225, 853), but no detectable change of significance could be found in the central venous (right atrial mean or right ventricular end diastolic) or hepatic venous mean pressures. There was no change in heart rate in two and a late slowing in one (no. 1196); this latter change probably was an additive late vagal effect. Splanchnic blood flow decreased in the two subjects in whom it was measured ( fig. 4 ). Unfortunately the state of these two men during nitrite collapse precluded prolonging the study in order to measure splanchnic blood volume. In these two patients the early nitrite effect on blood pressure was mild until the onset of collapse, and in one (no. 1225), the arterial pressure and contour change had occurred without an early change in cardiac output or splanchnic blood flow; then with MINUTES AFTER NTG Figure 4 The production of nitroglycerin collapse in a patient (no. 1225) in left ventricular failure (studied in the supine position). Collapse occurred at 18 minutes after sublingual NTG (shaded area). Prior to this the drug effect had been limited to a fall in pulmonary and systemic arterial pressures and a fall in resistances. With collapse, the shaded area of the graph, pulmonary and systemic pressures dropped markedly, as did splanchnic blood flow (ESBF). Right ventricular diastolic pressure probably did not change significantly (4 to 1 mm Hg) nor did hepatic venous pressure or heart rate. Because of the precarious level of blood pressure, the patient's legs were moved passively and his head lowered at 22 minutes (arrow) with rapid recovery. For discussion see text.
the collapse splanchnic flow fell 45%. By comparison another patient (no. 1391, table 2) had just as severe a drop in arterial pressures with a moderate fall in splanchnic flow and cardiac output of 19% and 17%, respectively, but no nitrite collapse. Figure 5 presents an additional, although preliminary, observation about the effects of nitroglycerin on the pulmonary blood volume. There appears to be an initial fall only in pulmonary artery mean pressure without change in pulmonary blood volume; then The efect of sublingual nitroglycerin on pulmonary blood volume (PBV) and pulmonary artery mean pressure (PAm) in a 59-year-old male with atherosclerotic heart disease, enlarged heart, old myocardial infarction, congestive heart failure, and normal sinus rhythm. During the first 12 minutes pressure declined without change in the pulmonary blood volume. There was no change in right ventricular diastolic or residual volumes (not shown on the graph). Subsequently pulmonary blood volume rose (a total of 110 ml or 17%) and the right ventricular diastolic and residual volumes fell, 133 ml (30%) and 132 ml (33%), respectively, suggesting vasodilatation of the precapillary and venous pulmonary vascular beds. The control ratio of pulmonary blood volume to total blood volume of 13% is above normal, as expected in a patient with left ventricular failure. with little or no further pressure decline, the pulmonary volume rose 17%.
The response to nitroglycerin during supine leg exercise in case 1132 (table 3) was essentially the same as in the studies made at rest. This hypertensive male ( fig. 6 ) was in left ventricular failure at rest and had a marked increase in pulmonary hypertension on exercise and a normal increase13 in cardiac output (exercise factor of 1192) during this exertion. Following the drug, systemic pressures dropped, and the pulmonary arterial pressures returned to the resting or pre-exercise values. The cardiac output fell by 12% and the stroke volume by 28 ml or 40%6 of the exercise value before administration of the nitrite, and intermittent systemic pulsus alternans appeared. The latter had not been provoked by exercise alone. When this patient was no longer in failure, the study was repeated (values of the second study are not given in table 3 ). Although he had no Circulation, Volume XXXIII, March 1966 pulmonary hypertension (systolic, diastolic, and mean pressures were 25/5, 11) at rest, and basal resting output was unchanged, pulmonary hypertension (39/9, 19) reappeared during exercise; however, pulmonary artery pressures were again restored to resting levels 3 minutes after the dose of nitrite. Cardiac output again fell, but no pulsus alternans was provoked.
Discussion
The data presented indicate a widespread effect of nitroglycerin. As Honig and others'5 suggest, there is a fluctuating and multifaceted cardiovascular response to this drug which includes not only the effects on the coronary circulation but on several other regional circulations as well; the balance achieved in each patient may not necessarily be the same. The present report adds another circulatory effect to the general picture, namely the effect on the splanchnic bed, and The over-all blood flow decreased in 70% of these patients and remained at this lower level for about half an hour, indicating that this was not a fleeting effect of nitroglycerin. In animals, Honig and his associates'5 found an early rise in output soon followed by a fall suggesting that the latter was a result of declining venous return. Some authors2' 16 have seen a fall in cardiac output in man with nitroglycerin, while others, using amyl nitrite, describe both a rise in flow and in heart rate., 17, 18 Since neither of the latter circulatory responses occurred in the present study, it is probable that they result from the nasal irritant effect of amyl nitrite. Since the early work of Weiss and associates'19 20 nearly 20 years ago, venous pooling, presumably producing decreased venous return, has been implicated as a cause of reduced systemic blood flow. The site was presumed to be the capillaries and venules. Plethysmographic and other evidences have been added recently to confirm this peripheral vasodilatation.21, 22 The area in which venous pooling occurs is not yet identified. Although plethysmographic studies have suggested that the splanchnic bed was a likely site" this has not been confirmed by the present study. Rather, our findings suggest that if the splanchnic bed reacts at all, it does so in a manner suggesting over-all vasoconstriction with a diminished flow and a decrease in its blood volume.
It has been shown by Chasis and others23 that renal ischemia is elicited by nitrites with a decline in renal blood flow and glomerular filtration rate. Thus the combined splanchnic and renal circulations, which together receive more than half of the cardiac output, appear to react in opposite fashion to other peripheral areas such as skin and muscle.20 Furthermore, the arms and legs may not exhibit equal vasomotor alterations, the former being more affected than the latter. 19 However, having excluded gravitational influences by maintaining our patients supine throughout the study as opposed to Weiss and associates' studies'9' 20 where tilting was used, the only venous pressure values obtained in our subjects, the central and the hepatic, showed little or no discernible change. This was also found by Brachfeld and associates.' These pressures, however, are not very sensitive to flow or volume changes and are not necessarily indicative of peripheral venous pressure which has been found to decline with nitroglycerin.'9' 20 It is interesting to note in this regard that, with a falling cardiac output and presumably a falling venous return to the right heart, the pulmonary blood volume rises. Apparently the pulmonary vascular bed, in contrast to the renal and hepatic, undergoes vasodilatation of considerable magni-tude24 as is suggested by the fall in pulmonary arterial pressure found in every one of our patients and also noted by others." 22, 24, 25 In our patients this was accompanied by a decrease in right ventricular volumes at rest. Moreover, the fall in pulmonary arterial pressure occurs even during exercise, when cardiac output and hence pulmonary blood flow have increased.
The most consistent single finding in this study was the change in the arterial blood vessels, both systemic and pulmonary. The decline in pressure which was predominantly systolic in these two systems, the distinctive contour change, and the lack of corresponding change in systemic resistance, all point to influences which affect predominantly the elastic arteries as opposed to muscular (or more peripheral) arteries.26 The contour alteration was less apparent in the femoral artery curve, which supports this notion, since Bader26 stated that arteries more distal than the common iliac belong to the muscular vessel type. The effect on the elastic vessels was an early drug response and appeared in our study before any change in stroke volume had begun. This change in distensibility of the arteries was recognized clinically with the first use of nitrites and a "bounding" pulse quality was described." However, which of the three elements of the vascular wall of these arteries,26 the collagen tissue, elastic tissue, or smooth muscle, is largely responsible Circulation, Volume XXXIII, March 1 966 for the contour change is still not known. Recent work26 suggests that elastic and collagen tissues control the contour or shape of the arterial stretch curve and yet nitroglycerin is known to alter smooth muscle tone. Hence, all three elements may be involved.
The dislocation or even loss of the dicrotic or incisural notch, a finding noted also by others ,'5 17, 18, 27, 28 could be a damping phenomenon. This is suggested by the comment of Remington29 who, in comparing central with peripheral arterial pressure curves, noted that the contour change of the normal femoral artery, in which the incisural notch is greatly diminished and a narrow systolic profile is seen-essentially a loss of the central pulse feature-is the result of a damping effect. He noted also that the changes are most obvious when pressure is low. This is certainly true of the nitroglycerin-induced alterations as well and one could say that "femoralization" of the brachial curve (figs. 1 and 3) occurs when pressure has fallen considerably. Remington29 stated that "viscoelastic properties of the (arterial) wall are more prominent at low pressure levels." If nitroglycerin has an effect on such properties, it would, therefore, be more evident at low levels of arterial pressure. Alterations in the large vessel walls by nitrites would also be felt in the resonant properties of these vessels and might alter reflected waves and these in turn would influence pulse contour.
The appearance of arterial pulsus alternans after administration of nitroglycerin, as found in this study, has not been reported previously. It appeared independently of changes in blood pressure or cardiac output. Since it may be that nitrites influence the resonance of the large arterial bed, especially that part between the aorta and the femoral arteries, this alternation may be another evidence of a change in resonance induced by nitroglycerin. A resonance effect has been postulated30 in the production of pulsus alternans under other circumstances. A myocardial origin for this cyclic phenomenon is unlikely since no effect by nitroglycerin has been found on myocardial contractility."' 31, 32 Unfortunately Circulalion, Volum7e XXXIII, March 1966 there are no data known to us on the effects of nitrites on myocardial or smooth muscle action potentials or ionic fluxes. 34 Brachfeld, 33 in a recent review, stated that the extensive pharmacological activity of nitroglycerin includes effects upon cellular respiration and energy metabolism, inhibiting phosphoryla-tion15 and ATP activity and decelerating the latter's breakdown. 34 Thus the means by which nitrites produce pulsus alternans can only be speculated upon at present, and the solution awaits further cellular investigation.
The mechanism of nitroglycerin collapse was not greatly elucidated by this study, except to show that splanchnic blood flow falls markedly, along with the decline in cardiac output. The other changes in pressure were merely quantitatively larger than those that occurred with the drug in other subjects or earlier in the study of the same subject ( fig. 4 ). Pulse rate change was not an integral part of the picture and the central venous and hepatic venous pressures were not appreciably altered. It is noteworthy that collapse occurred despite the supine position. Previous investigators had induced collapse by tilting the subjects thus adding a gravitational influence to that of the drug. '9, 20 The peripheral pooling, which is thought to occur to an excessive degree in collapse, is said to be the basis of the frequently found lowered cardiac output. It probably resides in the postarteriolar (capillary-venular) bed, although this is not really proved as yet. Neither is the location of the tissue sites in which most of the blood is pooled. In view of our present study the splanchnic bed, at least in the supine position, is not a very likely reservoir. This is an unexpected finding as splanchnic pooling had been assumed."1, 20 Certainly sequestration of large volumes of blood outside the active vascular channels was not found since total circulating volume (TBV) was unaltered during the effect of nitroglycerin. Small volume changes could, of course, escape detection.
Summary
Splanchnic, pulmonary, and systemic hemodynamics were studied in 18 patients after the sublingual administration of nitroglycerin. The drug, contrary to expectations, produced an over-all vasoconstrictive effect on the splanchnic circulation rather than vasodilatation. There was no evidence of venous pooling in this bed, and indeed the data may indicate a splanchnic supportive role in augmenting venous return to the heart with disengorgement of its own volume. In contrast, there was vasodilatation and pooling of blood in the pulmonary vascular bed. The systemic circulation probably sustains several effects by nitroglycerin, including arterial vasodilatation. A direct change in large artery distensibility probably explains the modest fall in systolic blood pressure seen. Further decline in arterial pressure may depend on venous pooling of a small or large degree. Probably the fall in systemic and specific organ flows is also linked to decreased venous return and the vascular readjustments provoked thereby. Pulsus alternans was produced by nitroglycerin, a previously unreported effect of the drug, but the mechanism by which it arose could not be defined.
Tercentary of the Publication of Sydenham's Treatise on Acute Diseases Excerpt from: Epistle "Dedicatory to the First Edition" to Robert Boyle, 1666 Upon these grounds I earnestly request you to look upon my little work with a favorable eye, and to lend it the ornament of your name; and as no one knows better than yourself the difference between things swollen out, and things really great, I hope that will not find less favour for being neither vast in bulk, nor stuffed out with the spoils of former authors: I have no wish to disturb their ashes. 
